{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:19:09Z","timestamp":1787066349205,"version":"build-2736575974"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126859","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T14:04:31Z","timestamp":1431698671000},"page":"e0126859","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Increased Expression of Angiogenic and Inflammatory Proteins in the Vitreous of Patients with Ischemic Central Retinal Vein Occlusion"],"prefix":"10.1371","volume":"10","author":[{"given":"Christoph","family":"Ehlken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Grundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Schlunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00fcrgen T.","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Pielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.124.5.726","article-title":"Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study","volume":"124","author":"S Cugati","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"S Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e78538","DOI":"10.1371\/journal.pone.0078538","article-title":"Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review","volume":"8","author":"A Pielen","year":"2013","journal-title":"PloS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study","volume":"118","author":"PA Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","article-title":"Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study","volume":"155","author":"DM Brown","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ophtha.2012.06.037","article-title":"Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study","volume":"119","author":"DL Epstein","year":"2012","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ophtha.2012.07.080","article-title":"A longitudinal analysis of risk factors associated with central retinal vein occlusion","volume":"120","author":"MS Stem","year":"2013","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0953-6205(02)00025-0","article-title":"Cardiovascular and thrombophilic risk factors for central retinal vein occlusion","volume":"13","author":"D Prisco","year":"2002","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study","volume":"114","author":"P Mitchell","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ophtha.2012.09.033","article-title":"The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study","volume":"120","author":"JQ Zhou","year":"2013","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajo.2011.01.040","article-title":"Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion","volume":"152","author":"C Ehlken","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e8158","DOI":"10.1371\/journal.pone.0008158","article-title":"Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases","volume":"4","author":"T Yoshimura","year":"2009","journal-title":"PloS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Y Suzuki","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IAE.0b013e3182993d74","article-title":"Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema","volume":"34","author":"H Noma","year":"2014","journal-title":"Retina Phila Pa"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/IAE.0b013e3181eef419","article-title":"Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion","volume":"31","author":"A Sodi","year":"2011","journal-title":"Retina Phila Pa"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00417-006-0501-5","article-title":"Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases","volume":"245","author":"HC Hasselbach","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch F\u00fcr Klin Exp Ophthalmol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: natural history of visual outcome","volume":"41","author":"SS Hayreh","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"AI Saeed","year":"2003","journal-title":"BioTechniques"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/j.1755-3768.2011.02292.x","article-title":"Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion","volume":"90","author":"MJ Koss","year":"2012","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-9255-8-38","article-title":"Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series","volume":"8","author":"H Noma","year":"2011","journal-title":"J Inflamm Lond Engl"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1874364101307010011","article-title":"Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography","volume":"7","author":"M Koss","year":"2013","journal-title":"Open Ophthalmol J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/112067211002000222","article-title":"Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion","volume":"20","author":"H Noma","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"ref24","first-page":"re12","article-title":"Integration of oxygen signaling at the consensus HRE","volume":"2005","author":"RH Wenger","year":"2005","journal-title":"Sci STKE Signal Transduct Knowl Environ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-4-12","article-title":"Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1\/CCL2) and MCP-5 (Ccl12) in astrocytes","volume":"4","author":"J Mojsilovic-Petrovic","year":"2007","journal-title":"J Neuroinflammation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/FJC.0b013e31815f248d","article-title":"Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury","volume":"51","author":"R Natarajan","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jcp.21558","article-title":"The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1","volume":"217","author":"P Simon M-","year":"2008","journal-title":"J Cell Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkp425","article-title":"An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia","volume":"37","author":"Y Benita","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2010.00961.x","article-title":"Regulation of the Ifng locus in the context of T-lineage specification and plasticity","volume":"238","author":"A Balasubramani","year":"2010","journal-title":"Immunol Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00424-005-1413-7","article-title":"Hypoxia-responsive transcription factors","volume":"450","author":"EP Cummins","year":"2005","journal-title":"Pfl\u00fcg Arch Eur J Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"L Boring","year":"1998","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"L Gu","year":"1998","journal-title":"Mol Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1074\/jbc.M111.284034","article-title":"ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3","volume":"287","author":"S Ghosh","year":"2012","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1161\/01.CIR.0000130643.41587.DB","article-title":"In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade","volume":"109","author":"N Hashiya","year":"2004","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.20022027","article-title":"VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization","volume":"198","author":"S Ishida","year":"2003","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2001.tb03934.x","article-title":"Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis","volume":"947","author":"Y Sato","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/sj.onc.1205297","article-title":"Hepatocyte growth factor\/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway","volume":"21","author":"R Paumelle","year":"2002","journal-title":"Oncogene"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/bbrc.2001.5927","article-title":"Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1","volume":"289","author":"M Oikawa","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10","volume":"126","author":"S Chang","year":"2006","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/ATVBAHA.108.172528","article-title":"VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis","volume":"28","author":"CH Ha","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.84.7.732","article-title":"Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy","volume":"84","author":"A Cant\u00f3n","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"ref43","first-page":"200","article-title":"Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy","volume":"21","author":"JZ Cui","year":"2007","journal-title":"Eye Lond Engl"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-8993(99)02097-1","article-title":"Differential expression of hepatocyte growth factor and its receptor, c-Met in the rat retina during development","volume":"851","author":"W Sun","year":"1999","journal-title":"Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bjo.2008.148841","article-title":"Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes","volume":"93","author":"K Kinnunen","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"ref46","author":"R Seitz","year":"1962"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"182060","DOI":"10.1155\/2013\/182060","article-title":"Osteoprotegerin as a marker of atherosclerosis in diabetic patients","volume":"2013","author":"A Augoulea","year":"2013","journal-title":"Int J Endocrinol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"A Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"164134","DOI":"10.1155\/2008\/164134","article-title":"Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure","volume":"2008","author":"GJ Elias","year":"2008","journal-title":"Mediators Inflamm"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/sj.bjp.0704936","article-title":"Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets","volume":"137","author":"A Radomski","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.thromres.2007.06.002","article-title":"Role of metalloproteinases in platelet function","volume":"121","author":"MJ Santos-Mart\u00ednez","year":"2008","journal-title":"Thromb Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/ATVBAHA.109.194589","article-title":"Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation","volume":"29","author":"J Orbe","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/CIRCULATIONAHA.111.047100","article-title":"Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism","volume":"124","author":"J Orbe","year":"2011","journal-title":"Circulation"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/jlb.67.4.471","article-title":"The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation","volume":"67","author":"E Brandt","year":"2000","journal-title":"J Leukoc Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.gastro.2005.09.032","article-title":"Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells","volume":"130","author":"L Kruidenier","year":"2006","journal-title":"Gastroenterology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2013.11.040","article-title":"Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima\u2013media thickness","volume":"232","author":"C Tan","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T01:08:08Z","timestamp":1566695288000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126859"}},"subtitle":[],"editor":[{"given":"Keisuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126859","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}